Novartis Pharmaceuticals Corp

FDA Filings

This page includes the latest FDA filings for Novartis Pharmaceuticals Corp. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.

FDA Registration(s)
Registration Number3002037047
FEI Number3002037047
NameS.A. ALCON-COUVREUR N.V.
Owner & OperatorNovartis Pharmaceuticals Corporation
Contact AddressOne Health Plaza
East Hanover NJ 07936 US
Official Correspondent
  • Corey Schmidt
  • x-862-7782266-x
US Agent
Registration Status1
Initial ImporterN
Registration Expiration2020-04-25
Registration AddressRIJKSWEG 14
Puurs, 2870 BE
Establishment TypeManufacture Medical Device for Another Party (Contract Manufacturer)



FDA Filings

Device
Company
DeviceDate
Novartis Pharmaceuticals Corporation
Prescription Medication2024-11-20
Novartis Pharmaceuticals Corporation
Prescription Medication2024-11-08
Novartis Pharmaceuticals Corporation
Prescription Medication2024-11-03
Novartis Pharmaceuticals Corporation
Prescription Medication2024-11-03
Novartis Pharmaceuticals Corporation
Prescription Medication2024-11-03
Novartis Pharmaceuticals Corporation
Prescription Medication2024-11-01
Novartis Pharmaceuticals Corporation
Prescription Medication2024-10-22
Novartis Pharmaceuticals Corporation
Prescription Medication2024-10-13
Novartis Pharmaceuticals Corporation
Prescription Medication2024-10-01
Novartis Pharmaceuticals Corporation
Prescription Medication2024-09-27
Novartis Pharmaceuticals Corporation
Prescription Medication2024-09-26
Novartis Pharmaceuticals Corporation
Prescription Medication2024-09-20
Novartis Pharmaceuticals Corporation
Prescription Medication2024-08-23
Novartis Pharmaceuticals Corporation
Prescription Medication2024-08-15
Novartis Pharmaceuticals Corporation
Prescription Medication2024-08-09
Novartis Pharmaceuticals Corporation
Prescription Medication2024-08-08
Novartis Pharmaceuticals Corporation
Prescription Medication2024-08-08
Novartis Pharmaceuticals Corporation
Prescription Medication2024-08-02
Novartis Pharmaceuticals Corporation
Prescription Medication2024-07-30
Novartis Pharmaceuticals Corporation
Prescription Medication2024-07-24
Novartis Pharmaceuticals Corporation
Prescription Medication2024-07-24
Novartis Pharmaceuticals Corporation
Prescription Medication2024-07-24
Novartis Pharmaceuticals Corporation
Prescription Medication2024-07-24
Novartis Pharmaceuticals Corporation
Prescription Medication2024-07-24
Novartis Pharmaceuticals Corporation
Prescription Medication2024-07-24
Novartis Pharmaceuticals Corporation
Prescription Medication2024-07-24
Novartis Pharmaceuticals Corporation
Prescription Medication2024-07-24
Novartis Pharmaceuticals Corporation
Prescription Medication2024-07-24
Novartis Pharmaceuticals Corporation
Prescription Medication2024-07-24
Novartis Pharmaceuticals Corporation
Prescription Medication2024-07-24
Novartis Pharmaceuticals Corporation
Prescription Medication2024-07-24
Novartis Pharmaceuticals Corporation
Prescription Medication2024-07-24
Novartis Pharmaceuticals Corporation
Prescription Medication2024-07-24
Novartis Pharmaceuticals Corporation
Prescription Medication2024-07-24
Novartis Pharmaceuticals Corporation
Prescription Medication2024-07-24
Novartis Pharmaceuticals Corporation
Prescription Medication2024-07-24
Novartis Pharmaceuticals Corporation
Prescription Medication2024-07-23
Novartis Pharmaceuticals Corporation
Prescription Medication2024-07-23
Novartis Pharmaceuticals Corporation
Prescription Medication2024-07-23
Novartis Pharmaceuticals Corporation
Prescription Medication2024-07-23
Novartis Pharmaceuticals Corporation
Prescription Medication2024-07-23
Novartis Pharmaceuticals Corporation
Prescription Medication2024-07-23
Novartis Pharmaceuticals Corporation
Prescription Medication2024-07-23
Novartis Pharmaceuticals Corporation
Prescription Medication2024-07-23
Novartis Pharmaceuticals Corporation
Prescription Medication2024-07-19
Novartis Pharmaceuticals Corporation
Prescription Medication2024-07-19
Novartis Pharmaceuticals Corporation
Prescription Medication2024-07-19
Novartis Pharmaceuticals Corporation
Prescription Medication2024-07-11
Advanced Accelerator Applications USA, Inc, Novartis Pharmaceuticals Corporation
Prescription Medication2024-07-11
Novartis Pharmaceuticals Corporation
Prescription Medication2024-07-10
Novartis Pharmaceuticals Corporation
Prescription Medication2024-07-04
Novartis Pharmaceuticals Corporation
Prescription Medication2024-07-04
Novartis Pharmaceuticals Corporation
Prescription Medication2024-07-04
Novartis Pharmaceuticals Corporation
Prescription Medication2024-07-04
Novartis Pharmaceuticals Corporation
Prescription Medication2024-07-04
Novartis Pharmaceuticals Corporation
Prescription Medication2024-07-04
Novartis Pharmaceuticals Corporation
Prescription Medication2024-07-04
Novartis Pharmaceuticals Corporation
Prescription Medication2024-07-02
Novartis Pharmaceuticals Corporation
Prescription Medication2024-07-02
Novartis Pharmaceuticals Corporation
Prescription Medication2024-07-02
Novartis Pharmaceuticals Corporation
Prescription Medication2024-07-02
Novartis Pharmaceuticals Corporation
Prescription Medication2024-07-02
Novartis Pharmaceuticals Corporation
Prescription Medication2024-07-02
Novartis Pharmaceuticals Corporation
Prescription Medication2024-07-02
Novartis Pharmaceuticals Corporation
Prescription Medication2024-07-02
Novartis Pharmaceuticals Corporation
Prescription Medication2024-07-02
Novartis Pharmaceuticals Corporation
Prescription Medication2024-06-27
Novartis Pharmaceuticals Corporation
Prescription Medication2024-06-22
Novartis Pharmaceuticals Corporation
Other Medication2024-06-21
Novartis Pharmaceuticals Corporation
Prescription Medication2024-06-18
Advanced Accelerator Applications USA, Inc, Novartis Pharmaceuticals Corporation
Prescription Medication2024-06-16
Novartis Pharmaceuticals Corporation
Prescription Medication2024-06-15
Novartis Pharmaceuticals Corporation
Prescription Medication2024-06-15
Novartis Pharmaceuticals Corporation
Prescription Medication2024-06-12
Novartis Pharmaceuticals Corporation
Prescription Medication2024-06-12
Novartis Pharmaceuticals Corporation
Prescription Medication2024-06-12
Novartis Pharmaceuticals Corporation
Prescription Medication2024-06-06
Novartis Pharmaceuticals Corporation
Prescription Medication2024-06-06
Novartis Pharmaceuticals Corporation
Prescription Medication2024-05-17
Novartis Pharmaceuticals Corporation
Prescription Medication2024-05-01
Novartis Pharmaceuticals Corporation
Other Medication2024-04-30
Novartis Pharmaceuticals Corporation
Prescription Medication2024-04-27
Novartis Pharmaceuticals Corporation
Prescription Medication2024-04-23
Novartis Pharmaceuticals Corporation
Prescription Medication2024-04-23
Novartis Pharmaceuticals Corporation
Prescription Medication2024-04-20
Novartis Pharmaceuticals Corporation
Prescription Medication2024-04-18
Novartis Pharmaceuticals Corporation
Prescription Medication2024-04-05
Novartis Pharmaceuticals Corporation
Prescription Medication2024-03-27
Novartis Pharmaceuticals Corporation
Prescription Medication2024-03-23
Novartis Pharmaceuticals Corporation
Prescription Medication2024-03-22
Novartis Pharmaceuticals Corporation
Prescription Medication2024-03-22
Novartis Pharmaceuticals Corporation
Prescription Medication2024-03-22
Novartis Pharmaceuticals Corporation
Prescription Medication2024-03-16
Novartis Pharmaceuticals Corporation
Prescription Medication2024-03-16
Novartis Pharmaceuticals Corporation
Prescription Medication2024-03-15
Novartis Pharmaceuticals Corporation
Prescription Medication2024-03-14
Novartis Pharmaceuticals Corporation
Prescription Medication2024-03-08
Novartis Pharmaceuticals Corporation
Prescription Medication2024-03-07
Novartis Pharmaceuticals Corporation
Prescription Medication2024-03-02
Novartis Pharmaceuticals Corporation
Prescription Medication2024-03-02
S.A. ALCON-COUVREUR N.V. [Novartis Pharmaceuticals Corporation]
Cellugel2019-04-29
S.A. ALCON-COUVREUR N.V. [Novartis Pharmaceuticals Corporation]
Provisc2019-04-29
S.A. ALCON-COUVREUR N.V. [Novartis Pharmaceuticals Corporation]
Viscoat, Duovisc and DiscoVisc2019-04-29
NOVARTIS PHARMACEUTICALS CORPORATION
Extavia® Auto-Injector II 2018-10-25
Novartis Pharmaceuticals Corporation
ZOFRAN2018-03-07
Novartis Pharmaceuticals Corporation
KYMRIAH2017-08-30
Novartis Pharmaceuticals Corporation
HYCAMTIN2017-07-07
Novartis Pharmaceuticals Corporation
Jadenu2017-05-18
Novartis Pharmaceuticals Corporation
KISQALI2017-03-13
Novartis Pharmaceuticals Corporation
Ilaris2016-12-22
Novartis Pharmaceuticals Corporation
HYCAMTIN2016-12-21
Novartis Pharmaceuticals Corporation
Sandostatin LAR Depot2016-07-22
Novartis Pharmaceuticals Corporation
Sandostatin LAR Depot2016-07-22
Novartis Pharmaceuticals Corporation
VOTRIENT2016-07-12
Novartis Pharmaceuticals Corporation
Tafinlar2016-04-12
Novartis Pharmaceuticals Corporation
SEEBRI NEOHALER2015-10-29
Novartis Pharmaceuticals Corporation
ENTRESTO2015-07-07
Novartis Pharmaceuticals Corporation
FARYDAK2015-02-23
Novartis Pharmaceuticals Corporation
FARYDAK2015-02-23
Novartis Pharmaceuticals Corporation
Sandostatin LAR Depot2015-02-01
Novartis Pharmaceuticals Corporation
Signifor LAR2014-12-15
Novartis Pharmaceuticals Corporation
Signifor LAR2014-12-15
Novartis Pharmaceuticals Corporation
Signifor2012-12-14
Novartis Pharmaceuticals Corporation
Afinitor Disperz2012-08-29
Novartis Pharmaceuticals Corporation
Afinitor2010-07-09
Novartis Pharmaceuticals Corporation
Zortress2010-04-22
Novartis Pharmaceuticals Corporation
Zortress2010-04-22
Novartis Pharmaceuticals Corporation
Zortress2010-04-22
Novartis Pharmaceuticals Corporation
GenTeal Severe2009-09-14
Novartis Pharmaceuticals Corporation
EXTAVIA2009-08-14
Novartis Pharmaceuticals Corporation
Ilaris2009-06-18
Novartis Pharmaceuticals Corporation
Exforge HCT2009-04-04
Novartis Pharmaceuticals Corporation
Exforge HCT2009-04-04
Novartis Pharmaceuticals Corporation
Stalevo2008-09-26
Novartis Pharmaceuticals Corporation
Tasigna2007-10-29
Novartis Pharmaceuticals Corporation
Tasigna2007-10-29
Novartis Pharmaceuticals Corporation
Exelon2007-07-06
Novartis Pharmaceuticals Corporation
Exelon2007-07-06
Novartis Pharmaceuticals Corporation
Exforge2007-06-20
Novartis Pharmaceuticals Corporation
Exforge2007-06-20
Novartis Pharmaceuticals Corporation
Exforge2007-06-20
Novartis Pharmaceuticals Corporation
Reclast2007-04-01
Novartis Pharmaceuticals Corporation
Diovan HCT2006-04-28
Novartis Pharmaceuticals Corporation
Exjade2005-11-30
Novartis Pharmaceuticals Corporation
Exjade2005-11-30
Novartis Pharmaceuticals Corporation
Exjade2005-11-30
Novartis Pharmaceuticals Corporation
Focalin XR2005-05-31
Novartis Pharmaceuticals Corporation
Focalin XR2005-05-31
Novartis Pharmaceuticals Corporation
Focalin XR2005-05-31
Novartis Pharmaceuticals Corporation
Myfortic2004-02-27
Novartis Pharmaceuticals Corporation
Myfortic2004-02-27
Novartis Pharmaceuticals Corporation
Stalevo2003-06-11
Novartis Pharmaceuticals Corporation
Stalevo2003-06-11
Novartis Pharmaceuticals Corporation
Stalevo2003-06-11
Novartis Pharmaceuticals Corporation
Ritalin LA2002-06-05
Novartis Pharmaceuticals Corporation
Ritalin LA2002-06-05
Novartis Pharmaceuticals Corporation
Ritalin LA2002-06-05
Novartis Pharmaceuticals Corporation
Ritalin LA2002-06-05
Novartis Pharmaceuticals Corporation
Focalin2001-11-30
Novartis Pharmaceuticals Corporation
Focalin2001-11-30
Novartis Pharmaceuticals Corporation
Zometa2001-08-20
Novartis Pharmaceuticals Corporation
Diovan2001-07-01
Novartis Pharmaceuticals Corporation
Diovan2001-07-01
Novartis Pharmaceuticals Corporation
Diovan2001-07-01
Novartis Pharmaceuticals Corporation
Trileptal2001-05-30
Novartis Pharmaceuticals Corporation
Gleevec2001-05-15
Novartis Pharmaceuticals Corporation
Starlix2000-12-04
Novartis Pharmaceuticals Corporation
Starlix2000-12-04
Novartis Pharmaceuticals Corporation
Exelon2000-04-30
Novartis Pharmaceuticals Corporation
Exelon2000-04-30
Novartis Pharmaceuticals Corporation
Exelon2000-04-30
Novartis Pharmaceuticals Corporation
Exelon2000-04-30
Novartis Pharmaceuticals Corporation
Trileptal2000-01-30
Novartis Pharmaceuticals Corporation
Comtan1999-10-19
Novartis Pharmaceuticals Corporation
Vivelle-Dot1999-01-08
Novartis Pharmaceuticals Corporation
Vivelle-Dot1999-01-08
Novartis Pharmaceuticals Corporation
Vivelle-Dot1999-01-08
Novartis Pharmaceuticals Corporation
Vivelle-Dot1999-01-08
Novartis Pharmaceuticals Corporation
Sandostatin1998-10-21
Novartis Pharmaceuticals Corporation
Simulect1998-05-12
Novartis Pharmaceuticals Corporation
Simulect1998-05-12
Novartis Pharmaceuticals Corporation
Diovan HCT1998-03-06
Novartis Pharmaceuticals Corporation
Diovan HCT1998-03-06
Novartis Pharmaceuticals Corporation
Diovan HCT1998-03-06
Novartis Pharmaceuticals Corporation
TOBI1997-12-22
Novartis Pharmaceuticals Corporation
Femara1997-07-31
Novartis Pharmaceuticals Corporation
Lamisil1996-05-10
Novartis Pharmaceuticals Corporation
Neoral1995-07-14
Novartis Pharmaceuticals Corporation
Neoral1995-07-14
Novartis Pharmaceuticals Corporation
Neoral1995-07-14
Novartis Pharmaceuticals Corporation
Lotrel1995-03-03
Novartis Pharmaceuticals Corporation
Lotrel1995-03-03
Novartis Pharmaceuticals Corporation
Lotrel1995-03-03
Novartis Pharmaceuticals Corporation
Lotrel1995-03-03
Novartis Pharmaceuticals Corporation
Sandimmune1990-03-02
Novartis Pharmaceuticals Corporation
Sandimmune1990-03-02
Novartis Pharmaceuticals Corporation
1989-09-30
Novartis Pharmaceuticals Corporation
Sandostatin1988-10-21
Novartis Pharmaceuticals Corporation
Sandostatin1988-10-21
Novartis Pharmaceuticals Corporation
Sandostatin1988-10-21
Novartis Pharmaceuticals Corporation
Sandostatin1988-10-21
Novartis Pharmaceuticals Corporation
Sandimmune1983-11-14
Novartis Pharmaceuticals Corporation
Sandimmune1983-11-14
Novartis Pharmaceuticals Corporation
Desferal1968-04-02
Novartis Pharmaceuticals Corporation
Ritalin1955-12-31

Similar & Related FDA Registered Companies

Related Finance Registrations
U.S. Import Records [external site]
Import IDShipmentCargo DescriptionQuantity
2020051442848Anvers,Belgium -> New York, New YorkPHARMACEUTICAL FINISHED PRODUCTS TR1301 BOX
2020051239184Anvers,Belgium -> New York, New YorkPHARMACEUTICAL FINISHED PRODUCTS TR1301 BOX
2020050939228Anvers,Belgium -> New York, New YorkPHARMACEUTICAL FINISHED PRODUCTS TR1301 BOX
2020050763108Anvers,Belgium -> New York, New YorkPHARMACEUTICAL FINISHED PRODUCTS TR1301 BOX
2020050646238Anvers,Belgium -> New York, New YorkPHARMACEUTICAL FINISHED PRODUCTS TR1301 BOX
2020050562041Anvers,Belgium -> New York, New YorkPHARMACEUTICAL FINISHED PRODUCTS TR1301 BOX
2020050151390Anvers,Belgium -> New York, New YorkPHARMACEUTICAL FINISHED PRODUCTS TR1301 BOX
2019102420806Anvers,Belgium -> New York/Newark Area, Newark, New JerseyPHARMACEUTICAL FINISHED PRODUCTS1282 BOX

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.